The outlook of companies tied to Viagra's history presents a complex investment picture . While the initial boom generated substantial profits , generic copies have significantly diminished sales . Investing in related pharmaceutical companies now requires a careful assessment of proprietary rights , evolving healthcare changes, and the prospect fo